Siga Technologies (SIGA) EBIT Growth (1y) (2011 - 2025)
Powered by 
Analysis
Siga Technologies (SIGA) EBIT Growth (1y) (2011 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 7.43% |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 31.43% |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | -111.70% |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | -2.34% |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | -15.58% |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | -27.06% |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 31.60% |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | -9.25% |
| 10 | Siga Technologies | 235.60 Mn | 80.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -1,985.78% |
| Jun 30, 2025 | 4,130.25% |
| Mar 31, 2025 | -120.00% |
| Dec 31, 2024 | -37.73% |
| Sep 30, 2024 | 141.40% |
| Jun 30, 2024 | 123.28% |
| Mar 31, 2024 | 634.81% |
| Dec 31, 2023 | 5,179.92% |
| Sep 30, 2023 | -103.05% |
| Jun 30, 2023 | -251.05% |
| Mar 31, 2023 | -46.52% |
| Dec 31, 2022 | -101.92% |
| Sep 30, 2022 | 1,556.34% |
| Jun 30, 2022 | 278,548.91% |
| Mar 31, 2022 | 27.67% |
| Dec 31, 2021 | 250.80% |
| Sep 30, 2021 | -108.95% |
| Jun 30, 2021 | -100.00% |
| Mar 31, 2021 | 50.24% |
| Dec 31, 2020 | 872.43% |